Description
On February 6-7th, 2017, the World Health Organization met with over 200 stakeholders to present Rehabilitation 2030: a call for action. The aims of this meeting were 1) "to draw attention to the increasing unmet needs for rehabilitation;" 2) "to highlight the role of rehabilitation in achieving the Sustainable Development Goals (SDGs) proposed by the United Nations;" and 3) "to call for coordinated and concerted global action towards strengthening rehabilitation in health systems." Rehabilitation is the key health strategy for the UN's SDG #3 with the aim of optimizing function and supporting those with health conditions to achieve as much independence as possible and be productive members of society. Rehabilitation 2030 presents a framework through which we can scale up efforts to promote, strengthen, and integrate rehabilitation services across the globe.
This session will review the WHO's Rehabilitation 2030 Goals, specifically highlighting the most tangible calls to action and will be presented by Dr. Haylee Yepson. We will then focus on a group discussion to choose which of these strategies the International Rehab and Global Health Community can realistically focus on to help fulfill the goals set forth by the UN and the WHO thereby strengthening and promoting the field of physiatry. Our final goal is to then identify current, active projects globally where these strategies can be applied, and build our IRGH Medical Mission Directory for students, trainees, and attendings interested in Global Health.
Learning Objectives
Learning Objective 1: Examine the key components and targets outlined in the WHO Rehabilitation 2030 framework and their
implications for healthcare systems worldwide.
Learning Objective 2: Analyze the role of interdisciplinary collaboration and innovation in advancing progress towards the WHO
Rehabilitation 2030 goals.
Learning Objective 3: Discuss the challenges and opportunities in achieving the WHO Rehabilitation 2030 goals, including
barriers to access, resource allocation, and policy implementation.
Learning Objective 4: Propose strategies for advocacy, research, and community engagement to support the realization of the
WHO Rehabilitation 2030 vision and promote inclusive, equitable access to rehabilitation services globally.
Member Community
International Rehabilitation and Global Health
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
Faculty
Niña Carmela Tamayo, DO: Disclosed no relevant financial relationships.
Haylee Yepson, DO: Disclosed no relevant financial relationships.
AAPM&R Medical Education Committee
John C. Cianca, MD: Ownership or partnership with Musculoskeletal Ultrasound Consultants, LLC.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
Rachel A. Brakke Holman, MD: Disclosed no relevant financial relationships.
Joseph E. Burris, MD: Serves on the Speakers Bureau for, and received clinical research grants from Allergan.
David S. Cheng, MD: Disclosed no relevant financial relationships.
Theresa A. Gillis, MD: Disclosed no relevant financial relationships.
Kevin N. Hakimi, MD: Disclosed no relevant financial relationships.
Matthew T. Haas, MD: Disclosed no relevant financial relationships.
R.Samuel Mayer, MD: Royalties from Demos Medical Publishing.
Ameet S. Nagpal, MD MS MEd: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Royalities from Demos Publishing; board member, American Board of Physical Medicine and Rehabilitation.
Sarah M. Smith, MD: Disclosed no relevant financial relationships.
Stephanie Tow, MD: Disclosed no relevant financial relationships.
Kevin R. VIncent, MD, PhD: Disclosed no relevant financial relationships.
AAPM&R CME Committee
Karen P. Barr, MD: Disclosed no relevant financial relationships.
Cherry C. Junn, MD: Disclosed no relevant financial relationships.
Sheryl R. Levin, MD: Disclosed no relevant financial relationships.
Kentaro Onishi, DO: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
Cynthia G. Pineda, MD: Disclosed no relevant financial relationships.
Patricia T. Tan, MD: Disclosed no relevant financial relationships.
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Kristin A. Wong, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.